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that can be used to counsel male patients with OAB symptoms in pre-
dicting the presence of BOO.
IPD14:
DIABETES MELLITUS PATIENTS REQUIRE HIGHER RATES OF
CONTINUING MEDICATION AFTER TRANSURETHRAL RESECTION OF
PROSTATE: IMPLICATIONS FROM TAIWAN NATIONWIDE POPULATION-
BASED COHORT STUDY
Chen-Pang Hou, Phei-Lang Chang, Chien-Lun Chen, Yu-Hsiang Lin, Pei-
Shan Yang, Ke-Hung Tsui. Department of Urology, Chang Gung Memorial
Hospital, Taoyuan, Taiwan
Purpose: The aim of this study was to compare the clinical outcomes
between diabetic patients and non-diabetic patients receiving transure-
thral resection of prostate (TUR-P).
Materials and Methods: This analysis was a retrospective cohort study
using 13 years (2000e2012) of claims data from Taiwan’s National Health
Insurance Research Database (NHIRD). A total of 4887 patients who had
persistent lower urinary tract symptoms (LUTS) and underwent TUR-P for
benign prostate hyperplasia (BPH) were enrolled and divided into two
groups: Diabetes mellitus (DM) group and Non-DM group. The patients’
characteristics, post-operative clinical outcomes, and the medication re-
cords after TUR-P were compared.
Results: Therewas no difference between the two groups in regards to age,
ratio of urinary tract infection (UTI) and urinary retention before surgery.
The pre-operative medication statuses were also similar between the two
groups. However, DM group patients had a higher prevalence of comor-
bidities. Post-operatively, the DM group had lower rates of UTI (OR, 0.78;
p¼0.009) and higher rates of urinary retention requiring catheterization
(OR, 1.35; p¼0.01) within 1 month after TUR-P. Both of the proportions
became insigniﬁcantly different during the 1 month to 1 year post-oper-
ative period. A higher proportion of patients with DM took anti-musca-
rinics (OR, 1.23; P ¼ 0.032) within the ﬁrst 3 months and a-blockers (OR,
1.18; P¼ 0.049) during 3e12months after receiving TUR-P. Overall, the DM
group patients had a worse post-operative medication-free survival
compared to that of non-DM group patients (95% CI¼1.14; p¼0.005).
Conclusion: Diabetes Mellitus patients require higher rates of continuing
medication after TUR-P, especially anti-muscarinics in three months post-
op and alpha-blocker after three months post-op. Diabetes Mellitus pa-
tients also had higher incidence of urine retention after surgery.
IPD15:
ONE-YEAR ANATOMIC OUTCOMES OF LAPAROSCOPIC SACROCOL-
POPEXY IN KAMEDA MEDICAL CENTER
Ting-Wen Huang, Jimmy Masayoshi Nomura, Shingo Moriyama, Shino
Tokiwa. Urogynecology Center, Kameda Medical Center, Japan
Purpose: For pelvic organ prolapse (POP) patients, voiding dysfunction is
associated with the increasing severity of cystocele. After surgical
correction of the prolapse, 89% patients had normalization of voiding
dysfunction (Fitzgerald MP, 2000). Prolapse repair surgery plays an
important role to resolve female lower urinary symptoms. Particularly,
laparoscopic sacrocolpopexy (LSC) provides the outcomes of the gold
standard abdominal approach while offering the beneﬁts of minimally
invasive surgery (Gabriel B, 2011). Since 2014, LSC became a new option for
POP patients covered by public health insurance in Japan. The aim of this
study is to clarify the postoperative anatomical change after LSC in Kameda
Medical Center.
Materials and Methods: We did a retrospective medical chart review
between April and December 2014 for patients who underwent LSC and
being followed up for one year in our center. The anatomical change was
assessed by using POP-Q. Recurrence rate and speciﬁc site were also
investigated.
Results: A total of 146 patients, aged 65.1±7.8, with average BMI 23.4±2.8,
were retrospectively enrolled. Average blood loss was 22.8±25.7ml with
238.5±45.3 minutes in operation time. For anatomical change assessed by
POP-Q, Aa changed from 1.1±1.4 to 2.9±0.3; Ba changed from 2.5±2. to
2.9±0.4; C changed from 1.4±3 to 7.4±1.4;gh changed from 4.4±1.1 to3.7±0.8; pb changed from 3.5±0.7 to 3.7±0.5; tvl changed from 8.1±1.1 to
8.6±1.2; Ap changed from 0±1.6 to 2.8±0.6; Bp changed from 0.6±2.4 to
2.7±0.7; D changed from 3.2±2.5 to 8.3±1.4. Aa, Ba, C, gh, tvl, Ap, Bp,
and D of POP-Q showed signiﬁcant differences between pre- and post-
operation. 8 patients (5.5%) showed recurrence during ﬁrst year after LSC.
2 patents were found to have recurrent anterior vaginal wall prolapse
while 7 patients had recurrent posterior wall prolapse. However, using
PFDI-20 to assess the feeling of a bulge for recurrent patients, no one felt a
bulge in the vaginal area.
Conclusion: POP patients receiving LSC showed signiﬁcant improvement
in anatomical outcome. Rate of recurrence in ﬁrst year after LSC was
about 5%.
IPD16:
EFFECTIVENESS OF NO-CGMP AXIS FOR LOWER URINARY TRACT
SYNDROME
Yukihide Matsui, Yurika Ito, Tomo Shimizu, Yota Nakajima, Toshihiro
Shimizu, Mizuki Kasahara, Koji Tamura, Toshihiro Tai, Masato
Nagata, Humito Yamabe, Kuri Aoki, Hideyuki Kobayashi, Koichi
Nagao, Koichi Nakajima. Department of Urology, Faculty of Medicine, Toho
University, Japan
Purpose: It is well known NO-cGMP axis plays a critical role in treatment
for erectile dysfunction. NO-cGMP axis is expected to not only ED but also
LUTS treatment due to regulate the smooth muscle relaxation. ZalutiaⓇ is
one of the PDE5 inhibitor launched in Japan on 2013 for LUTS treatment.
We evaluated the effectiveness of ZalutiaⓇ for LUTS and ED treatment.
Material and Methods: Between October 2014 and December 2015, 108
patients were prescribed ZalutiaⓇ 5mg per day in Toho University Medical
center Omori Hospital. Of 36patients were clinically evaluable such as PSA
level, prostate volume, IPSS (International prostate symptom score),
ﬂowmetry, EHS (erectile hardness score) and the diary of voiding.
Results: Effective rate for urinary symptoms, especially storage symptoms
including nocturia, daytime frequency and urgency, was 53% and for ED
was 76%. Medication discontinuance was noted 13 cases. 5 cases were due
to no effective, 2 were due to appearance of a new symptom and 6 were
due to side effect including hated erecting. Though there was no
improvement of the urinary symptom, 5 patients wanted to continue the
medication.
Conclusion: PDE5 inhibitor is safe and effective for LUTS treatment. PDE5
inhibitor gives an effect to erectile function supplementary and seems to




OPERATING TIMES AND CLINICAL OUTCOMES IN PERCUTANEOUS
NEPHROLITHOTOMY: A COMPARISON OF TRACT DILATION METHODS
Kuo-Kang Feng, Yuan-Ju Lee, I-Ni Chiang, Sho-Mon Wang, Kuo-How
Huang, Hong-Chiang Chang. Department of Urology, National Taiwan
University Hospital, College of Medicine, National Taiwan University, Taipei,
Taiwan
Purpose: The study investigated that two different tract dilatation method
affect operating times and bleeding complications associated with
percutaneous nephrolithotomy (PCNL) in the single-center study.
Materials and Methods: All patients who underwent PCNL for primary or
secondary treatment of kidney stone indications during the study period
(January, 2013 to August, 2015) were eligible for inclusion. PCNL pro-
cedures were performed according to local clinical guidelines and prac-
tices. Nephrostomy tract dilation was performed using balloon dilation or
Amplatz serial dilation. Hematologic complications assessed included
bleeding rates, transfusion rates, and preoperative and postoperative he-
moglobin values. Hospital stay (days) and the stone free rate are also
included into outcome parameters.
Results: The median operating time with balloon dilation (n ¼ 142) was
signiﬁcantly shorter than Amplatz serial dilation (n ¼54) at 88.0 vs 135.9
minutes, respectively (P < 0.0001). In the balloon dilation group, there was
Abstracts / Urological Science 27 (2016) S24eS35 S29signiﬁcantly less of drop in hemoglobin (1.3 vs 2.0 g/dL, respectively; P <
0.0001) and shorter hospital stay (6.93 vs 7.89 days, respectively, P ¼
0.047). Transfusions rate in balloon dilation group has no signiﬁcantly
difference compared with the Amplatz serial dilator group (15.4% vs 20.3%,
respectively; P ¼ 0.418). Univariate analysis revealed the use of balloon
dilation has shorter operating time, less of drop in hemoglobin level and
less hospital stay. Bymultivariate analysis, the use of balloon dilator reduce
43% bleeding risk although not reached statistical signiﬁcance (Odds ratio
[OR] 0.57; P ¼ 0.121). Other signiﬁcant predictive factors included oper-
ating time, and stone burden.
Conclusion: This study shows that in PCNL, the use of balloon dilator has
shorter operating time. Factors that are associated with bleeding/trans-
fusion include operating time and stone burden.
IPD18:
PERCUTANEOUS NEPHROLITHOTOMY FOR RENAL STONES INCREASE
THE RISK OF DEVELOPING HYPERTENSION IN CHINESE/TAIWANESE
POPULATION
Tsu-Ming Chien 1, Yen-Man Lu 1, Yii-Her Chou 1,2, Chun-Nung
Huang 1,2. 1Division of Urology, Kaohsiung Medical University Hospital,
Kaohsiung, Taiwan; 2 School of Medicine, Kaohsiung Medical University,
Kaohsiung, Taiwan
Purpose: Percutaneous nephrolithotomy (PCNL) is a minimally-invasive
procedure to remove stones from the renal pelvis by a small puncture
wound through the skin. Some common complications include hemor-
rhage during the operation, and post operation infection were reported.
Other uncommon complications such as hemothorax or hydrothothorax
were also noticed. However, long-term follow up data were seldom re-
ported. The association between PCNL and development of new hyper-
tension has never been reported before. We aimed to determine whether
the PCNL increased the development of hypertension with controls
matched for age, gender, obesity, diabetes mellitus and hyperlipidemia by
using the Taiwan National Health Insurance (NHI) database.
Materials and Methods: Data sourced from the “Longitudinal Health In-
surance Database” (LHID200) of our country (Taiwan, Republic of China)
compiled by the NHI from 1996 to 2010. The LHID200 include medical
records for 1,000,000 individuals randomly sampled from all enrollers in
NHI. Cases of renal stones were deﬁned by the ICD-9 diagnostic codes as
592. Patients with newly onset of hypertension was deﬁned as ICD-9
diagnostic codes 401 to 405 with hypertension medication. For the study
group, we only include the renal stone patients underwent PCNL (proce-
dure code 76016B), patients with diagnosis of renal stone who underwent
either shock wave lithotripsy (SWL; procedure code: 50023B) or ureter-
orenoscopic lithotripsy (URSL; procedure code: 77026B, 77027B, 77028B)
were precluded in our cohort. For control group, we included the patients
with renal stones diagnosed but did not receive the SWL, PCNL and URSL.
The Kaplan-Meier analysis was applied to estimate the effect of PCNL on
hypertension free rates.
Results: We included 232 patients with PCNL and 1,160 patients with
comparison. There were no difference in age, gender, urbanization,
monthly income, and co-morbidities between the two groups. Patients
underwent PCNL showed greater incidence with a hazard ration of 1.48
(95% CI: 1.13e1.95) for newly hypertension compared to the control group.
The incidence rate of newly hypertension during the follow up period was
44.5 per 1,000 person-years.
Conclusion: On the basis of our results, PCNL may increase the risk of
developing hypertension in Taiwan NHI database.
IPD19:
THE CLINICAL EFFICACY OF RECTAL SWAB CULTURE BEFORE
TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY FOR
PREVENTING INFECTIVE COMPLICATIONS AND CHARACTERISTICS OF
QUINOLONE RESISTANT ESCHERICHIA COLI ISOLATED FROM THE
RECTAL SWAB
Yoshiki Hiyama 1, Satoshi Takahashi 2, Teruhisa Uehara 3, Koji
Ichihara 1, Jiro Hashimoto 4, Masahiro Yanase 5, Keisuke
Taguchi 6, Takaoki Hirose 7, Masanori Matsukawa 8, Yasuharu
Kunishima 9, Hiroshi Hotta 10, Noki Ito 4, Koh Takeyama 11, HitoshiTachiki 12, Naoya Masumori 1. 1Department of Urology, School of Medicine,
Sapporo Medical University, Japan; 2Department of Infection Control and
Laboratory Medicine, School of Medicine, Sapporo Medical University,
Japan; 3Division of Urology, Muroran City General Hospital, Japan;
4Division of Urology, NTT East Sapporo Hospital, Japan; 5Division of
Urology, Sunagawa City Medical Center, Japan; 6Division of Urology, Oji
General Hospital, Japan; 7Division of Urology, Japan Community Health
Care Organization Hokkaido Hospital, Japan; 8Division of Urology,
Takikawa Municipal Hospital, Japan; 9Division of Urology, National
Hospital Organization Hokkaido Medical Center, Japan; 10Division of
Urology, Japanese Red Cross Asahiawa Hospital, Japan; 11Division of
Urology, Hakodate National Hospital, Japan; 12Division of Urology, Steel
Memorial Muroran Hospital, Japan
Purpose: Transrectal ultrasound guided (TRUS) prostate biopsy is per-
formed for the detection of prostate cancer. Fluoroquinolone has been
used as the primary prophylactic agent before biopsy worldwide. How-
ever, not negligible number of cases with severe infectious complications
caused by ﬂuoroquinolone resistant Escherichia coli (QREC) have been re-
ported recently. We evaluated the outcome of our regimen by targeted
prophylaxis using rectal swab culture and investigated characteristics of
clinical isolated QREC.
Materials andMethods: This study was done from June 2013 to December
2014. The swabs were cultured on agar plate containing 2 mg/ml levo-
ﬂoxacin and one containing 1 mg/ml sitaﬂoxacin before TRUS guided
prostate biopsy. Patients with susceptible organisms received levoﬂoxacin
or sitaﬂoxacin while those with resistant organisms received directed
antimicrobial prophylaxis according to the results of antimicrobial sus-
ceptibility test. All of QREC were susceptible to amikacin and meropenem.
We identiﬁed the patients with infectious complications after TRUS guided
prostate biopsy and backgrounds of QREC carriers from medical reports.
Results: A total of 397 men underwent TRUS guided prostate biopsy.
Median age was 69 year-old, median serum PSA levels 7.4 ng/ml, median
prostate volume 37.7 ml, respectively. Seventy four (18.6%) patients had
QREC. All of QREC were susceptible to amikacin and meropenem. The risk
factors of possible QREC were comorbidity with diabetes mellitus and
hospitalization within prior 12 months. Three (0.7%) patients of 390 pa-
tients received appropriate antimicrobial prophylaxis showed high grade
fever after TRUS guided prostate biopsy. However, the pathogens were not
QREC.
Conclusion: Targeted antimicrobial prophylaxis could be associated with
reducing severe infectious complications caused by QREC. When the pa-
tients having potential risk factors being QREC carrier undergo biopsy,
rectal swab culture and modiﬁed antimicrobial prophylaxis should be
considered.
IPD20:
MISUSE OF DETECTION METHODS MAY ASSOCIATED TO INCREASED
RESISTANCE OF GONOCOCCAL INFECTION: EXPERIENCES FROM A
NORTHERN TAIWAN INSTITUTE
Yu-Hua Lin 1, Hsu-Che Huang 1, Bing-Jun Jiang 1, Chun-Hou Liao 1. 1Division
of Urology, Department of Surgery, Cardinal Tien Hospital, New Taipei City,
Taiwan
Purpose: To examine the detection rate of the routine urine culture and
genital discharge swab culture for the detection gonoccocal urethritis in
male patients. In addition, we evaluated the results of urinalysis for
gonococcal infection and investigated the drug sensitivity of Neisseria
gonorrhoeae strains isolated from these patients.
Materials and Methods: From August 2009 to October 2015, 202 males
diagnosed with gonococcal infection, based on the results of urine culture
or genital discharge swab culture, were enrolled in this study. Initial
clinical symptoms and urinalysis results were collected. The susceptibility
of N. gonorrhoeae to penicillin, cefmetazole, cefotaxime, ceftazidime,
cefuroxime, ceftriaxone and oﬂoxacin were determined using agar plate
dilution method.
Results: The mean age of the patients was 29.67 ± 10.39 year, and 157 of
the 202 male patients (87.6%) were aged between 15 and 34 years. We
determined that the diagnostic value of genital discharge swab culture
was signiﬁcantly higher than that of the urine culture (90.9% vs 67.4%,
